Form 4: Northwest Biotherapeutics Executive Marnix L. Bosch Reports Gift of Stock Options

Chief Technical Officer Marnix L. Bosch reports gifting 3,000,000 stock options to family members for estate planning purposes.

Summary

• Marnix L. Bosch, Chief Technical Officer of Northwest Biotherapeutics Inc., filed a Form 4 with the SEC on August 11, 2024.
• The form reports a transaction that occurred on August 9, 2024, where Bosch gifted 3,000,000 stock options to family members.
• These options have an exercise price of $0.35 and expire on July 2, 2030.
• The underlying security for the options is common stock with a par value of $0.001.
• Following the transaction, Bosch directly owns 4,549,157 derivative securities.
• The gift was made for estate planning purposes to family members who do not share the same residence.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a gift of stock options. It doesn't inherently convey positive or negative sentiment regarding the company's performance or outlook.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. Gifts of stock options can be part of estate planning strategies.

Stakeholder Impact

• The gift of stock options could potentially impact the recipients (family members) through future financial gains if the options are exercised profitably.
• The transaction itself has minimal direct impact on other stakeholders.

Key Dates